Cash flows from operating activities | |
Net loss | |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
Depreciation and amortization | 249.47K |
Interest from amortization of debt discount | |
Interest from amortization of debt costs | |
Gain on sale of property and equipment | |
Stock based compensation | 119.94K |
Change in provision for doubtful accounts receivable | 0 |
Deferred rent | -32.35K |
Changes in operating assets and liabilities: | |
Trade accounts receivables | 232.47K |
Other receivables | 88.07K |
Inventories | -227.97K |
Prepaid expenses and other assets | 34.14K |
Accounts payable and accrued liabilities | 361.13K |
Net cash provided by (used in) operating activities | 921.89K |
Cash flows from investing activities | |
Purchase of property and equipment | -387.26K |
Proceeds from sale of equipment | |
Net cash used in investing activities | -387.26K |
Cash flows from financing activities | |
Proceeds from exercise of stock options | |
Proceeds from sale of common stock from employee stock purchase plan | 9.6K |
Deferred costs associated with equity financing | |
Costs associated with conversion of debentures | |
Exercise of warrants | 70.96K |
Net cash provided by (used in) financing activities | 45.26K |
Effect of exchange rate on cash and cash equivalents | 95.86K |
Decrease in cash and cash equivalents | 675.75K |
Cash and cash equivalents, beginning of period | 2.91M |
Cash and cash equivalents, end of period | 3.58M |
Supplemental disclosure of cash flow information: | |
Interest paid in cash | 6.94K |
Income taxes paid | 116.04K |
Supplemental disclosure of non-cash investing & financing activities: | |
Convertible debentures converted into common stock | |
Accrued deferred costs associated with equity financing | |
Prepaid interest on convertible debentures through the issuance of common stock |